Eurofins: downgraded by broker
Acknowledging that Eurofins shares have had a difficult 2022, the broker believes that the challenges facing the bio-analysis provider 'could continue into 2023', and sees a risk to earnings consensus in the near term.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction